Presently, Mark Wingertzahn occupies the position of Chief Scientific Officer for Wesana Health Holdings, Inc.

He is also Associate Professor at New York Institute of Technology.

He previously held the position of Head-Development, SVP-Research & Development at Kaleido Biosciences, Inc.